On 10 February 2026, Shandong Weigao Group Medical Polymer Company Limited repurchased 61,600 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 5.24 to HKD 5.27, for a total of HKD 323,984. The shares were added to treasury, bringing the treasury share count from 40,948,400 to 41,010,000.

Following the repurchase, the number of issued H shares (excluding treasury shares) stood at 4,481,322,324, compared to an opening balance of 4,481,383,924. The total number of issued shares (including treasury shares) remains 4,522,332,324.

The repurchase fell under a mandate dated 27 May 2025, which authorized Shandong Weigao to buy back up to 451,560,392 shares. As of the latest update, 34,361,600 shares have been repurchased under this mandate, representing 7.6095% of the total issued shares as at the date of the mandate. The resulting moratorium period for any new share issue or sale of treasury shares extends until 13 March 2026.